Drug allergy

RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon

Retrieved on: 
Tuesday, February 20, 2024
Liver, SAN, Drug allergy, Autoimmune disease, RAPT, FDA, Atopic dermatitis, Food, Asthma, COVID-19, Inflammation, Letter, Liver failure, Safety, History, Therapy, Patient, Q&A, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced that the U.S. Food and Drug Administration (FDA) has verbally notified the company that a clinical hold has been placed on the company’s Phase 2b trial of zelnecirnon (RPT193) in atopic dermatitis and its Phase 2a trial in asthma. The company expects to receive a formal clinical hold letter from the FDA. The clinical hold determination was based on a serious adverse event of liver failure in one patient in the atopic dermatitis trial, the cause of which is currently unknown but which has been characterized as potentially related to zelnecirnon. Dosing of zelnecirnon has been halted in both clinical trials, as has enrollment of new trial participants. The clinical hold does not apply to RAPT’s ongoing trial of tivumecirnon (FLX475) in oncology.

Key Points: 
  • The company expects to receive a formal clinical hold letter from the FDA.
  • Dosing of zelnecirnon has been halted in both clinical trials, as has enrollment of new trial participants.
  • The clinical hold does not apply to RAPT’s ongoing trial of tivumecirnon (FLX475) in oncology.
  • The live webcast and audio archive of the presentation may be accessed on the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations .

Fellowship-Trained Allergist and Immunologist Karina Rotella, MD Joins ENT and Allergy Associates, LLP Yorktown Heights, NY Office

Retrieved on: 
Wednesday, March 22, 2023
Allergy, Abstract, LLP, Drawing, Asthma, Drug, Education, Food allergy, Friends, Icahn School of Medicine at Mount Sinai, Drug allergy, Dermatitis, Food, Immunodeficiency, SUNY Downstate Medical Center, American Academy, Atopic dermatitis, American Academy of Allergy, Asthma, and Immunology, Alpha Omega Alpha, Hives, AOA, Norwegian Asthma and Allergy Association, Biomedicine, MD, Patient, Cooking, Physician, Child, Partnership, Grand Rounds, Growth, Immunology, American College, Family, Medical device, Nursing, Pediatrics, Medicine

Tarrytown, New York, March 22, 2023 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA), is proud to announce that fellowship-trained allergist and immunologist Karina Rotella, MD will join their Yorktown Heights office effective August 1, 2023.

Key Points: 
  • Tarrytown, New York, March 22, 2023 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA), is proud to announce that fellowship-trained allergist and immunologist Karina Rotella, MD will join their Yorktown Heights office effective August 1, 2023.
  • During this transition, Dr. Peter Gontzes will cover the Yorktown Heights office to ensure a seamless care transition for patients.
  • She is a member of the American College of Allergy, Asthma & Immunology, the American Academy of Allergy, Asthma & Immunology, and the New York Allergy and Asthma Society.
  • Rotella is the perfect fit for our Yorktown Heights office,” noted Dr. Debra Reich, Senior Partner at the Yorktown Heights office of ENTA.

ENT and Allergy Associates, LLP Continues to Expand its Allergy Division Welcomes Fellowship-Trained Allergist/Immunologist Maylene Xie, MD to Hackensack, NJ

Retrieved on: 
Tuesday, February 14, 2023
Internal, Gold, Drug allergy, Health, Primary immunodeficiency, Immunodeficiency, Physician, Allergy, Food, University of Pittsburgh Medical Center, Yale University, Abstract, LLP, Internal medicine, Otorhinolaryngology, Dance, Food allergy, American Academy of Allergy, Asthma, and Immunology, Allergist, Hives, Patient, Asthma, Angioedema, Allergic rhinitis, Cooking, University, Research, Dermatitis, Family, Reading, Wilfrid Sellars, Immunology, Knowledge, American Academy, Partnership, FACS, University of Pittsburgh School of Medicine, Drug, American College, Norwegian Asthma and Allergy Association, Grand Rounds, Quality of life, CCC, Matt Walsh (political commentator), Nursing, Medical device, Science, Psychology, MD

She has also published numerous peer-reviewed journal articles and abstracts in the fields of food allergy, primary immunodeficiency, transplant immunology, and medical education.

Key Points: 
  • She has also published numerous peer-reviewed journal articles and abstracts in the fields of food allergy, primary immunodeficiency, transplant immunology, and medical education.
  • She is a member of the American College of Allergy, Asthma & Immunology, and the American Academy of Allergy, Asthma & Immunology.
  • She will join otolaryngologists Robin M. Brody, MD; Won-Taek Choe, MD; Steven M. Gold, MD; Jonathan A. Lesserson, MD; Jared M. Wasserman, MD, FACS and Jay Agarwal, MD, along with audiologists Olivia Galioto, Au.D.
  • “Maylene brings with her an extensive experience and expertise in the field of allergy and immunology.

Allergist/Immunologist Misu Paul, MD to Join ENT and Allergy Associates, LLP In Bay Ridge and Dyker Heights Brooklyn, NY

Retrieved on: 
Wednesday, January 11, 2023
Otorhinolaryngology, Allergy, Teaching hospital, Internal medicine, Hindi, Asthma, American College of Allergy, Asthma and Immunology, Immunotherapy, American Board of Commissioners for Foreign Missions, Throat, American College, Ear, American Academy of Allergy, Asthma, and Immunology, Knowledge, Hives, Norwegian Asthma and Allergy Association, LLP, Patient, Baylor College of Medicine, American Academy, Atopic dermatitis, Allergist, Research, Audiology, Drug allergy, American Board of Internal Medicine, Dermatitis, Food allergy, Nose, Baylor University, The Stony Brook School, Immunology, Medical device, Adult, MD, Medicine

Dr. Paul is board certified by the American Board of Internal Medicine and the American Board of Allergy and Immunology.

Key Points: 
  • Dr. Paul is board certified by the American Board of Internal Medicine and the American Board of Allergy and Immunology.
  • Dr. Paul is active in the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.
  • In Bay Ridge, Dr. Paul will work side-by-side with otolaryngologists Ramez Habib, MD, Christopher Song, MD, and Wesley Davidson, MD.
  • In Dyker Heights, she will join otolaryngologists Leon Chen, MD and Wayne Chung, MD.

AAAAI Installs New President, Dr. David Khan, at 2022 Annual Meeting

Retrieved on: 
Monday, February 28, 2022
Federation of Clinical Immunology Societies, Literature, Resident, Program, AAAAI, Asthma, CAE, University, American Academy, Pediatrics, Lists of diseases, Clinical professor, Business, Joint task force, Editing, Legacy Good Samaritan Medical Center, Allergy, Asthma & Immunology Research, Champaign County, Illinois, American Academy of Allergy, Asthma, and Immunology, Hives, Food allergy, Conference, Allergist, Patient, Drug allergy, Publication, Journal, Internal medicine, MD, University of Texas Southwestern Medical Center, Research, Good Samaritan Hospital, Mayo Clinic, Pharmaceutical industry, Allergy, Immunology, Anaphylaxis

PHOENIX, Feb. 28, 2022 /PRNewswire-PRWeb/ -- The American Academy of Allergy, Asthma & Immunology (AAAAI) is pleased to introduce its 2022-2023 President, David A. Khan, MD, FAAAAI.

Key Points: 
  • PHOENIX, Feb. 28, 2022 /PRNewswire-PRWeb/ -- The American Academy of Allergy, Asthma & Immunology (AAAAI) is pleased to introduce its 2022-2023 President, David A. Khan, MD, FAAAAI.
  • He was installed as AAAAI President this afternoon during the Business Meeting that took place on the final day of the 2022 AAAAI Annual Meeting in Phoenix, Arizona.
  • He has remained active in this society for over 20 years, chairing the annual TAAIS meeting since its inception and the Resident's Conference for 15 years.
  • Megan Brown, CAE, Senior Media & Member Communications Manager, American Academy of Allergy, Asthma & Immunology, (414) 272-6071, [email protected]
    SOURCE American Academy of Allergy, Asthma & Immunology